Abnova Taiwan Financials
| 4133 Stock | TWD 28.80 0.20 0.70% |
Abnova |
Understanding current and past Abnova Taiwan Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Abnova Taiwan's financial statements are interrelated, with each one affecting the others. For example, an increase in Abnova Taiwan's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Abnova Taiwan's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Abnova Taiwan Corp. Check Abnova Taiwan's Beneish M Score to see the likelihood of Abnova Taiwan's management manipulating its earnings.
Abnova Taiwan Stock Summary
Abnova Taiwan competes with Sinphar Pharmaceutical, WiseChip Semiconductor, Novatek Microelectronics, Leader Electronics, and Information Technology. Abnova Corporation manufactures and sells various recombinant proteins and antibodies. Abnova Corporation is headquartered in Taipei, Taiwan. ABNOVA CORPORATION operates under Biotechnology classification in Taiwan and is traded on Taiwan Stock Exchange.| Instrument | Taiwan Stock View All |
| Exchange | Taiwan Stock Exchange |
| ISIN | TW0004133004 |
| Business Address | No 108, Jhouzih |
| Sector | Life Sciences Tools & Services |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.abnova.com |
| Phone | 886 2 8751 1888 |
| Currency | TWD - New Taiwan Dollar |
You should never invest in Abnova Taiwan without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Abnova Stock, because this is throwing your money away. Analyzing the key information contained in Abnova Taiwan's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Abnova Taiwan Key Financial Ratios
There are many critical financial ratios that Abnova Taiwan's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Abnova Taiwan Corp reports annually and quarterly.| Return On Equity | 0.0505 | |||
| Return On Asset | 0.0227 | |||
| Target Price | 102.08 | |||
| Number Of Employees | 14 | |||
| Beta | 0.42 |
Abnova Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Abnova Taiwan's current stock value. Our valuation model uses many indicators to compare Abnova Taiwan value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Abnova Taiwan competition to find correlations between indicators driving Abnova Taiwan's intrinsic value. More Info.Abnova Taiwan Corp is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.45 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Abnova Taiwan Corp is roughly 2.22 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Abnova Taiwan's earnings, one of the primary drivers of an investment's value.Abnova Taiwan Corp Systematic Risk
Abnova Taiwan's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Abnova Taiwan volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-eight with a total number of output elements of thirty-three. The Beta measures systematic risk based on how returns on Abnova Taiwan Corp correlated with the market. If Beta is less than 0 Abnova Taiwan generally moves in the opposite direction as compared to the market. If Abnova Taiwan Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Abnova Taiwan Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Abnova Taiwan is generally in the same direction as the market. If Beta > 1 Abnova Taiwan moves generally in the same direction as, but more than the movement of the benchmark.
Abnova Taiwan December 3, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Abnova Taiwan help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Abnova Taiwan Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Abnova Taiwan Corp based on widely used predictive technical indicators. In general, we focus on analyzing Abnova Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Abnova Taiwan's daily price indicators and compare them against related drivers.
| Information Ratio | (0.38) | |||
| Maximum Drawdown | 3.75 | |||
| Value At Risk | (1.17) | |||
| Potential Upside | 0.678 |
Additional Tools for Abnova Stock Analysis
When running Abnova Taiwan's price analysis, check to measure Abnova Taiwan's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abnova Taiwan is operating at the current time. Most of Abnova Taiwan's value examination focuses on studying past and present price action to predict the probability of Abnova Taiwan's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abnova Taiwan's price. Additionally, you may evaluate how the addition of Abnova Taiwan to your portfolios can decrease your overall portfolio volatility.